발행물
컨퍼런스
ESMO Asia
,
Interim analysis (IA) of SPADE: a prospective, real-world study of avelumab first-line maintenance (1LM) treatment in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) in the Asia-Pacific (APAC) region
ASCO 2024
The prognosis for patients with bladder cancer with recurrence after pathologic complete response or pathologic downstaging after radical cystectomy: EUMC RC cohort study.
Integrative genomic analysis examines molecular and clinical disparities between bladder urothelial carcinoma and upper tract urothelial carcinoma.
EMUC 23
FOur Cycles of platinum-based chemotherapy in advanced or metastatic Urothelial carcinoma Compared to Six Cycles: A retrospective cohort study (FOCUS, KCSG-GU23-08)
EMUC 2023
Impact of adjuvant chemotherapy in suboptimal neoadjuvant dose-dense MVAC followed by radical cystectomy for muscle- invasive bladder cancer